ACCORD Trademark

Trademark Overview


On Tuesday, August 30, 2022, a trademark application was filed for ACCORD with the United States Patent and Trademark Office. The USPTO has given the ACCORD trademark a serial number of 97570464. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Monday, September 9, 2024. This trademark is owned by Accord Healthcare, Inc.. The ACCORD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, non-prescription drugs and prescription medicine in the form of capsules, tablets, injectables, and creams for the treatment of medical conditions namely gout, depression, cancers, schizophrenia, opioid dependence withdrawal, anxiety, Parkinson's Disease, seizures, panic disorders, hypercalcemia, hypertension, multiple sclerosis, arrhythmia, hypercholesterolemia, diabetes, malaria, thyroid diseases, ADHD, asthma, allergies, transplant rejection prophylaxis, alcohol dependence, overactive bladder, pulmonary fibrosis, bipolar disorder, Restless leg syndrome, obsessive-compulsive disorder, premenstrual dysphoric disorder, post-traumatic stress disorder, hypertension, erectile dysfunction, atopic dermatitis, thrombosis, leukemia, Non-Hodgkin Lymphoma, skin infections, bloodstream infections, and hypotension
accord

General Information


Serial Number97570464
Word MarkACCORD
Filing DateTuesday, August 30, 2022
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateMonday, September 9, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of four hexagons interwoven in a clock formation where the top hexagon is dark orange, the right-side hexagon is orange, the lower hexagon is light orange and the left-side hexagon is peach, sitting above the word "accord" in lowercase stylized font where the "a", "r" and "d" are dark orange and the "c", "c" and "o" are grey.
Goods and ServicesPharmaceutical preparations, namely, non-prescription drugs and prescription medicine in the form of capsules, tablets, injectables, and creams for the treatment of medical conditions namely gout, depression, cancers, schizophrenia, opioid dependence withdrawal, anxiety, Parkinson's Disease, seizures, panic disorders, hypercalcemia, hypertension, multiple sclerosis, arrhythmia, hypercholesterolemia, diabetes, malaria, thyroid diseases, ADHD, asthma, allergies, transplant rejection prophylaxis, alcohol dependence, overactive bladder, pulmonary fibrosis, bipolar disorder, Restless leg syndrome, obsessive-compulsive disorder, premenstrual dysphoric disorder, post-traumatic stress disorder, hypertension, erectile dysfunction, atopic dermatitis, thrombosis, leukemia, Non-Hodgkin Lymphoma, skin infections, bloodstream infections, and hypotension
Indication of Colors claimedThe color(s) dark orange, orange, light orange, peach and grey is/are claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 16, 2022
Primary Code005
First Use Anywhere DateThursday, May 19, 2005
First Use In Commerce DateSunday, January 1, 2006

Trademark Owner History


Party NameAccord Healthcare, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Trademark Events


Event DateEvent Description
Friday, September 2, 2022NEW APPLICATION ENTERED
Friday, September 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 17, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, March 30, 2023ASSIGNED TO EXAMINER
Friday, March 31, 2023NON-FINAL ACTION WRITTEN
Friday, March 31, 2023NON-FINAL ACTION E-MAILED
Friday, March 31, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, June 23, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Friday, June 23, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Wednesday, September 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 16, 2024ASSIGNED TO LIE
Friday, February 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 20, 2024NON-FINAL ACTION WRITTEN
Tuesday, February 20, 2024NON-FINAL ACTION E-MAILED
Tuesday, February 20, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 20, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 22, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 22, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 16, 2024NON-FINAL ACTION WRITTEN
Tuesday, July 16, 2024NON-FINAL ACTION E-MAILED
Friday, July 19, 2024TEAS AMENDMENT OF USE RECEIVED
Tuesday, July 16, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, July 19, 2024USE AMENDMENT FILED
Friday, July 19, 2024AMENDMENT TO USE PROCESSING COMPLETE
Monday, September 9, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 9, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED